Its FDA-approved for weight loss in people with obesity or overweight and have a weight-related health issue, like type 2 diabetes or high blood pressure
Tukhovskaya EA, Ismailova AM, Shaykhutdinova ER, Slashcheva GA, Prudchenko IA, Mikhaleva II, Khokhlova ON, Murashev AN, Ivanov VT
Without randomized, long-term studies on the use of GLP-1 RAs in a large sample size of HS patients with a wide range of ages, comorbidities, risk factors, and sexes and without any confounding factors, it is difficult to conclusively determine whether GLP-1 RAs are a definitive treatment for HS
As the final enzyme in the synthesis pathway (BBD) is located in the liver, kidneys and in the brain, only these organs finalize the formation of L-carnitine from BB [29]
Safety and side effects: A meta-analysis of multiple studies in COPD patients showed no significant adverse effects at doses ranging from 600 mg to 3g/day.[ref] Studies in healthy adult athletes go up to 20g/day (not recommending this, just including it for safety).[ref] Conversely, in Parkinsons patients, there was a high number of adverse events at 6g/day of NAC
Having Hashimotos thyroiditis or standard hypothyroidism doesnt increase our risk of MTC